JP3580607B2 - Blood glucose measurement device using corneal natural fluorescence - Google Patents

Blood glucose measurement device using corneal natural fluorescence Download PDF

Info

Publication number
JP3580607B2
JP3580607B2 JP20773795A JP20773795A JP3580607B2 JP 3580607 B2 JP3580607 B2 JP 3580607B2 JP 20773795 A JP20773795 A JP 20773795A JP 20773795 A JP20773795 A JP 20773795A JP 3580607 B2 JP3580607 B2 JP 3580607B2
Authority
JP
Japan
Prior art keywords
corneal
blood glucose
value
fluorescence
natural fluorescence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP20773795A
Other languages
Japanese (ja)
Other versions
JPH0928671A (en
Inventor
晃敏 吉田
Original Assignee
晃敏 吉田
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 晃敏 吉田 filed Critical 晃敏 吉田
Priority to JP20773795A priority Critical patent/JP3580607B2/en
Publication of JPH0928671A publication Critical patent/JPH0928671A/en
Application granted granted Critical
Publication of JP3580607B2 publication Critical patent/JP3580607B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Landscapes

  • Eye Examination Apparatus (AREA)

Description

【0001】
【発明の属する技術分野】
本発明は血糖値を非侵襲で測定する装置に関するものである。
【0002】
【従来の技術】
血糖値の測定は糖尿病の病状診断や病後管理の重要な指標となるため、従来から種々の測定法が開発されている。現在では酵素法が中心であが、o−トルイジン−ホウ酸(o−TB)法を初め、種々の方法が行われている。しかし、いずれの方法もその都度採血を必要として患者に苦痛を与え、また検査に手間がかかる。
【0003】
本発明者は、眼球に可視から近赤外領域の間の選択された波長の励起光を照射し、ガラス体や水晶体からの自然螢光を測定して糖尿病患者と正常人との間で有意の差があることを報告している(臨眼,38(10) : 1059−1064, (1984) 参照)。眼球からの蛍光の測定は、fluorescein−Naを静脈に注射した後に行なうのが一般的であるが、自然蛍光はfluorescein−Naを静脈注射しないで測定された蛍光である。
【0004】
【発明が解決しようとする課題】
しかし、眼球の種々の場所からの自然蛍光と血糖値の相関関係については、今までのところ知見は得られていなかった。
本発明は眼球からの自然蛍光を利用して血糖値を非侵襲で測定できるようにすることを目的とするものである。
【0005】
【課題を解決するための手段】
本発明者は、眼球からの自然蛍光のうち、角膜自然蛍光の変動値が血糖値の変動値と相関のあることを見出し、本発明を出すに至った。すなわち、本発明は図1に示されるように、可視から近赤外領域の間の選択された波長の励起光を角膜に集光させ、その励起光による角膜からの自然蛍光を検出する光学系2と、
血糖変動値と角膜自然蛍光変動値との関係を保持しておき、各患者についての血糖値測定値を血糖値基準値とし、そのときの角膜自然蛍光検出値を角膜自然蛍光基準値としてそれぞれ記憶させておき、光学系2によるその後の角膜自然蛍光検出値と角膜自然蛍光基準値との差として角膜自然蛍光変動値を求め、前記関係からそれに対応する血糖変動値を求め、それを血糖値基準値と比較することによって各時点での絶対血糖値を求める演算部4とを備えて、血糖値を非侵襲で測定できるようにした装置である。
【0006】
インスリン非依存型糖尿病における増殖糖尿病網膜症(PDR)患者16名について同一の日の異なった時刻に角膜自然蛍光値と採血法による血糖値とを2回測定し、図2に示される血糖変動値と角膜自然蛍光変動値の関係を得た。これらのデータは相関係数r=0.648、p<0.01(pは危険率)の結果を示し、有意な正の相関を示している。図2に示されるような相関関係が演算部4に記憶されている。
一方、同時に測定した血糖変動値と水晶体自然蛍光変動値との間には、図3に示されるように、有意な相関は認められなかった。
【0007】
角膜自然蛍光から得られるのは血糖値の絶対値ではなく変動値であるので、絶対値を求めるためには、各患者について従来の採血による血糖値測定値とそのときの角膜自然蛍光検出値とを測定して基準値として記憶させておき、その後の角膜自然蛍光検出値とその基準値との差として角膜自然蛍光変動値を求め、それに対応する血糖変動値を求め、それを血糖値基準値と比較することによって各時点での絶対血糖値を求めることができる。血糖値基準値を求める測定を採血により行なうので、その採血は非侵襲ではないが、その後の測定には採血は必要ないので実質的に非侵襲ということができる。本発明における「非侵襲」とはこのように実質的に非侵襲なことを意味している。
【0008】
【実施例】
図4と図5より角膜自然蛍光値を測定する光学系の一例を説明する。図4は可視から近赤外領域の間の選択された波長の励起光を角膜に照射し、その励起光による角膜からの自然蛍光を検出する光学系を表わしたものである。角膜からの蛍光も選択的に検出できるようにするために、図4の光学系に図5に示す前眼部蛍光測定用アダプターを装着し、眼軸に沿った所定の深さの位置での蛍光を計測できるようにしている。
【0009】
光軸10に沿って固定レンズ12と走査レンズ14が配置されており、光軸10の走査レンズ14側の延長線上に被検体である眼球16がその眼軸が光軸10と一致するように配置される。光軸10上に設けられたレンズ18と眼球16の間には図4に示されるアダプター20が配置されている。
【0010】
眼球16に励起光を照射するために、励起光源22としてタングステンランプが設けられ、光源22からの連続波長光から所定波長光を励起光として取り出すフィルタ24、及び励起光を小さい系の光束とするスリット26を介して、所定波長で細く絞られた励起光28がミラー30で反射されてレンズ12,14に入射する。レンズ12,14で集光された励起光28は、レンズ18からアダプタ20を経て眼球の所定の深さの位置に集光されるようになっている。走査レンズ14を光軸に沿って移動させることにより、励起光28が集光される深さ位置が眼軸に沿って移動する。ここでは、特に励起光28が角膜に集光される。
【0011】
励起光照射により眼球16から発生した蛍光を検出するために、光軸16上で固定レンズ12側の延長線上には検出器スリット32、バリアフィルタ34を経て光電子増倍管(PMT)36が配置されている。
患者の眼球16の眼軸が光軸10と一致するように、光軸10上にターゲット用の光を発生する眼軸固定用ターゲット光源38が設けられ、その光がスリット40を経てビーム状になり、ビームスプリッタ41によって光軸10上に入射する。
【0012】
オペレータが患者の眼の位置を確認するために、光軸10と直交する光軸上にスプリットスクリーン42及びレンズ44を介して患者アライメントポート46が配置されており、患者アライメントポート46用の光軸と光軸10との交点にはミラー48が着脱可能に装着される。ミラー48が光軸10を横切るように配置されたときに患者アライメントポート46から患者の眼球16を確認することができる。
【0013】
また、光源の強度による検出値の補正を行なうために、ミラー48と一体的に組み立てられた校正用ガラス面50が設けられており、ミラー48が光軸10を横切る位置に配置されたときにそのガラス面50も光軸10上に配置され、光源22からの励起光がそのガラス面50で反射して検出器36へ入射し、光源強度が検出されるようになっている。
【0014】
【発明の効果】
本発明では採血法による血糖値と角膜自然蛍光値との関係を各患者について1度だけ測定しておけば、その後は角膜自然蛍光値を測定するだけで血糖値を非侵襲で求めることができる。そのため、糖尿病患者の病状判定や監視を容易に、かつ短時間に行なうことができるようになる。
【図面の簡単な説明】
【図1】本発明を示すブロック図である。
【図2】本発明における血糖変動値と角膜自然蛍光変動値との相関関係を示す図である。
【図3】比較例として、血糖変動値と水晶体自然蛍光変動値との相関関係を示す図である。
【図4】一実施例で用いた光学系を示す概略構成図である。
【図5】同実施例の光学系におけるアダプタを示す概略構成図である。
【符号の説明】
2 光学系
4 演算部
[0001]
TECHNICAL FIELD OF THE INVENTION
The present invention relates to an apparatus for non-invasively measuring a blood glucose level.
[0002]
[Prior art]
Since the measurement of the blood glucose level is an important index for diagnosing the condition of diabetes and managing it after disease, various measuring methods have been conventionally developed. At present, mainly the enzymatic method, various methods including the o-toluidine-boric acid (o-TB) method have been used. However, all of these methods require blood sampling each time, causing pain to the patient, and also require time and labor for the examination.
[0003]
The present inventors irradiate the eye with excitation light of a selected wavelength between the visible and near-infrared regions, measure the natural fluorescence from the vitreous body and the lens, and determine the significant difference between diabetic patients and normal persons. (See Shinkai, 38 (10): 1059-1064, (1984)). The measurement of fluorescence from the eyeball is generally performed after intravenous injection of fluorescein-Na, but the natural fluorescence is fluorescence measured without intravenous injection of fluorescein-Na.
[0004]
[Problems to be solved by the invention]
However, the correlation between the natural fluorescence from various places of the eyeball and the blood sugar level has not been obtained so far.
An object of the present invention is to make it possible to non-invasively measure a blood glucose level using natural fluorescence from an eyeball.
[0005]
[Means for Solving the Problems]
The present inventor has found that among natural fluorescence from the eyeballs, the fluctuation value of the corneal natural fluorescence has a correlation with the fluctuation value of the blood glucose level, and has led to the present invention. That is, as shown in FIG. 1, the present invention focuses an excitation light having a wavelength selected from the visible to the near-infrared region on the cornea, and detects natural fluorescence from the cornea due to the excitation light. 2 and
The relationship between the blood glucose fluctuation value and the corneal natural fluorescence fluctuation value is held, and the blood glucose measurement value for each patient is set as the blood glucose reference value, and the detected corneal natural fluorescence detection value at that time is stored as the corneal natural fluorescence reference value. The corneal spontaneous fluorescence fluctuation value is obtained as a difference between the subsequent corneal spontaneous fluorescence detection value by the optical system 2 and the corneal spontaneous fluorescence reference value. A calculation unit 4 for obtaining an absolute blood sugar level at each time point by comparing the blood sugar level with the measured value, so that the blood sugar level can be measured non-invasively.
[0006]
The corneal spontaneous fluorescence value and the blood glucose level were measured twice at different times of the same day on 16 patients with proliferative diabetic retinopathy (PDR) in non-insulin-dependent diabetes mellitus, and the blood glucose fluctuation values shown in FIG. And the relationship between the corneal spontaneous fluorescence fluctuation value was obtained. These data show the results of correlation coefficient r = 0.648, p <0.01 (p is the risk rate), indicating a significant positive correlation. The correlation as shown in FIG.
On the other hand, no significant correlation was observed between the blood glucose fluctuation value and the lens natural fluorescence fluctuation value measured at the same time, as shown in FIG.
[0007]
Since it is not the absolute value of the blood glucose level but the fluctuation value that is obtained from the corneal natural fluorescence, in order to obtain the absolute value, the blood glucose level measured value by the conventional blood sampling and the corneal natural fluorescence detection value at that time are obtained for each patient. Is measured and stored as a reference value, a corneal spontaneous fluorescence fluctuation value is obtained as a difference between the subsequent corneal spontaneous fluorescence detection value and the reference value, and a corresponding blood glucose fluctuation value is obtained. By comparing with, the absolute blood glucose level at each time point can be obtained. Since the measurement for obtaining the blood sugar level reference value is performed by blood sampling, the blood sampling is not non-invasive, but since subsequent blood sampling is not required, it can be said that the blood sampling is substantially non-invasive. “Non-invasive” in the present invention thus means substantially non-invasive.
[0008]
【Example】
An example of an optical system for measuring a corneal natural fluorescence value will be described with reference to FIGS. FIG. 4 shows an optical system that irradiates the cornea with excitation light having a selected wavelength in the visible to near-infrared region and detects natural fluorescence from the cornea due to the excitation light. In order to selectively detect the fluorescence from the cornea, the anterior ocular segment fluorescence measurement adapter shown in FIG. 5 is attached to the optical system shown in FIG. Fluorescence can be measured.
[0009]
A fixed lens 12 and a scanning lens 14 are arranged along the optical axis 10, and an eyeball 16, which is a subject, is on an extension of the optical axis 10 on the scanning lens 14 side so that the eye axis coincides with the optical axis 10. Be placed. An adapter 20 shown in FIG. 4 is arranged between the lens 18 provided on the optical axis 10 and the eyeball 16.
[0010]
In order to irradiate the eye 16 with the excitation light, a tungsten lamp is provided as the excitation light source 22, a filter 24 that extracts predetermined wavelength light from the continuous wavelength light from the light source 22 as the excitation light, and the excitation light is a small system light flux. Excitation light 28 narrowed down to a predetermined wavelength through the slit 26 is reflected by the mirror 30 and enters the lenses 12 and 14. The excitation light 28 condensed by the lenses 12 and 14 is condensed from the lens 18 via the adapter 20 to a position at a predetermined depth of the eyeball. By moving the scanning lens 14 along the optical axis, the depth position where the excitation light 28 is condensed moves along the eye axis. Here, in particular, the excitation light 28 is focused on the cornea.
[0011]
A photomultiplier tube (PMT) 36 is disposed on an extension of the fixed lens 12 on the optical axis 16 via the detector slit 32 and the barrier filter 34 in order to detect the fluorescence generated from the eye 16 by the irradiation of the excitation light. Have been.
An eye axis fixing target light source 38 for generating light for a target is provided on the optical axis 10 so that the eye axis of the patient's eyeball 16 coincides with the optical axis 10, and the light is beam-formed through a slit 40. And is incident on the optical axis 10 by the beam splitter 41.
[0012]
In order for an operator to confirm the position of the patient's eye, a patient alignment port 46 is disposed on an optical axis orthogonal to the optical axis 10 via a split screen 42 and a lens 44, and an optical axis for the patient alignment port 46 is provided. A mirror 48 is detachably mounted at the intersection of the optical axis 10 and the optical axis 10. The patient's eye 16 can be seen from the patient alignment port 46 when the mirror 48 is positioned across the optical axis 10.
[0013]
In order to correct the detection value based on the intensity of the light source, a calibration glass surface 50 integrally provided with the mirror 48 is provided. When the mirror 48 is disposed at a position crossing the optical axis 10, The glass surface 50 is also disposed on the optical axis 10 so that the excitation light from the light source 22 is reflected by the glass surface 50 and enters the detector 36, and the intensity of the light source is detected.
[0014]
【The invention's effect】
In the present invention, if the relationship between the blood glucose level and the corneal natural fluorescence value by the blood sampling method is measured only once for each patient, then the blood glucose level can be obtained noninvasively only by measuring the corneal natural fluorescence value. . Therefore, it becomes possible to easily and quickly determine and monitor the condition of a diabetic patient.
[Brief description of the drawings]
FIG. 1 is a block diagram illustrating the present invention.
FIG. 2 is a diagram showing a correlation between a blood glucose fluctuation value and a corneal natural fluorescence fluctuation value in the present invention.
FIG. 3 is a diagram showing a correlation between a blood glucose fluctuation value and a lens natural fluorescence fluctuation value as a comparative example.
FIG. 4 is a schematic configuration diagram showing an optical system used in one embodiment.
FIG. 5 is a schematic configuration diagram showing an adapter in the optical system of the embodiment.
[Explanation of symbols]
2 Optical system 4 Operation unit

Claims (1)

可視から近赤外領域の間の選択された波長の励起光を角膜に集光させ、その励起光による角膜からの自然蛍光を検出する光学系と、
血糖変動値と角膜自然蛍光変動値との関係を保持しておき、各患者についての血糖値測定値を血糖値基準値とし、そのときの角膜自然蛍光検出値を角膜自然蛍光基準値としてそれぞれ記憶させておき、前記光学系によるその後の角膜自然蛍光検出値と前記角膜自然蛍光基準値との差として角膜自然蛍光変動値を求め、前記関係からそれに対応する血糖変動値を求め、それを血糖値基準値と比較することによって各時点での絶対血糖値を求める演算部と、を備えたことを特徴とする非侵襲の血糖値測定装置。
An optical system that focuses excitation light of a selected wavelength between the visible and near-infrared regions on the cornea and detects natural fluorescence from the cornea due to the excitation light,
The relationship between the blood glucose fluctuation value and the corneal natural fluorescence fluctuation value is held, and the blood glucose measurement value for each patient is set as the blood glucose reference value, and the detected corneal natural fluorescence detection value at that time is stored as the corneal natural fluorescence reference value. The corneal spontaneous fluorescence fluctuation value is determined as the difference between the subsequent corneal spontaneous fluorescence detection value by the optical system and the corneal spontaneous fluorescence reference value, and the corresponding blood sugar fluctuation value is determined from the relationship, and the blood sugar level is calculated. A non-invasive blood glucose measurement device, comprising: a calculation unit that obtains an absolute blood glucose level at each time point by comparing with a reference value .
JP20773795A 1995-07-22 1995-07-22 Blood glucose measurement device using corneal natural fluorescence Expired - Lifetime JP3580607B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP20773795A JP3580607B2 (en) 1995-07-22 1995-07-22 Blood glucose measurement device using corneal natural fluorescence

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20773795A JP3580607B2 (en) 1995-07-22 1995-07-22 Blood glucose measurement device using corneal natural fluorescence

Publications (2)

Publication Number Publication Date
JPH0928671A JPH0928671A (en) 1997-02-04
JP3580607B2 true JP3580607B2 (en) 2004-10-27

Family

ID=16544710

Family Applications (1)

Application Number Title Priority Date Filing Date
JP20773795A Expired - Lifetime JP3580607B2 (en) 1995-07-22 1995-07-22 Blood glucose measurement device using corneal natural fluorescence

Country Status (1)

Country Link
JP (1) JP3580607B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5962302B2 (en) * 2012-07-30 2016-08-03 株式会社ニデック Fundus photographing device

Also Published As

Publication number Publication date
JPH0928671A (en) 1997-02-04

Similar Documents

Publication Publication Date Title
CA2718938C (en) Ocular imaging
US7828436B2 (en) Ocular imaging
JP2736002B2 (en) Device for in vivo measurement of optical properties of aqueous humor of the eye
Zeimer et al. A new method for rapid mapping of the retinal thickness at the posterior pole.
US6477394B2 (en) Non-invasive measurement of blood components using retinal imaging
US5377686A (en) Apparatus for detecting leakage from vascular tissue
CA2323434C (en) Spectroreflectometric measurement of oxygenation in a patient&#39;s eye
US5919132A (en) On-line and real-time spectroreflectometry measurement of oxygenation in a patient&#39;s eye
JP3580607B2 (en) Blood glucose measurement device using corneal natural fluorescence
JP2003532461A (en) Non-invasive measurement method using retinal image
AU2016201457B2 (en) Ocular Imaging
AU2012227222A1 (en) Ocular Imaging

Legal Events

Date Code Title Description
A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20040114

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20040120

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040322

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20040720

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20040720

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080730

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090730

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090730

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100730

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100730

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110730

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120730

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120730

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130730

Year of fee payment: 9

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term